» Articles » PMID: 38414296

MicroRNA-29c-tetrahedral Framework Nucleic Acids: Towards Osteogenic Differentiation of Mesenchymal Stem Cells and Bone Regeneration in Critical-sized Calvarial Defects

Overview
Journal Cell Prolif
Date 2024 Feb 28
PMID 38414296
Authors
Affiliations
Soon will be listed here.
Abstract

Certain miRNAs, notably miR29c, demonstrate a remarkable capacity to regulate cellular osteogenic differentiation. However, their application in tissue regeneration is hampered by their inherent instability and susceptibility to degradation. In this study, we developed a novel miR29c delivery system utilising tetrahedral framework nucleic acids (tFNAs), aiming to enhance its stability and endocytosis capability, augment the efficacy of miR29c, foster osteogenesis in bone marrow mesenchymal stem cells (BMSCs), and significantly improve the repair of critical-sized bone defects (CSBDs). We confirmed the successful synthesis and biocompatibility of sticky ends-modified tFNAs (stFNAs) and miR29c-modified stFNAs (stFNAs-miR29c) through polyacrylamide gel electrophoresis, microscopy scanning, a cell counting kit-8 assay and so on. The mechanism and osteogenesis effects of stFNAs-miR29c were explored using immunofluorescence staining, western blotting, and reserve transcription quantitative real-time polymerase chain reaction. Additionally, the impact of stFNAs-miR29c on CSBD repair was assessed via micro-CT and histological staining. The nano-carrier, stFNAs-miR29c was successfully synthesised and exhibited exemplary biocompatibility. This nano-nucleic acid material significantly upregulated osteogenic differentiation-related markers in BMSCs. After 2 months, stFNAs-miR29c demonstrated significant bone regeneration and reconstruction in CSBDs. Mechanistically, stFNAs-miR29c enhanced osteogenesis of BMSCs by upregulating the Wnt signalling pathway, contributing to improved bone tissue regeneration. The development of this novel nucleic acid nano-carrier, stFNAs-miR29c, presents a potential new avenue for guided bone regeneration and bone tissue engineering research.

Citing Articles

Current Understanding and Translational Prospects of Tetrahedral Framework Nucleic Acids.

Gu J, Liang J, Tian T, Lin Y JACS Au. 2025; 5(2):486-520.

PMID: 40017737 PMC: 11862954. DOI: 10.1021/jacsau.4c01170.


Current status of nano-embedded growth factors and stem cells delivery to bone for targeted repair and regeneration.

Liang W, Zhou C, Liu X, Xie Q, Xia L, Liu L J Orthop Translat. 2025; 50:257-273.

PMID: 39902262 PMC: 11788687. DOI: 10.1016/j.jot.2024.12.006.


MicroRNA-29c-tetrahedral framework nucleic acids: Towards osteogenic differentiation of mesenchymal stem cells and bone regeneration in critical-sized calvarial defects.

Sun J, Chen X, Lin Y, Cai X Cell Prolif. 2024; 57(7):e13624.

PMID: 38414296 PMC: 11216942. DOI: 10.1111/cpr.13624.

References
1.
Ma W, Yang Y, Zhu J, Jia W, Zhang T, Liu Z . Biomimetic Nanoerythrosome-Coated Aptamer-DNA Tetrahedron/Maytansine Conjugates: pH-Responsive and Targeted Cytotoxicity for HER2-Positive Breast Cancer. Adv Mater. 2022; 34(46):e2109609. DOI: 10.1002/adma.202109609. View

2.
Zhu G, Zheng J, Song E, Donovan M, Zhang K, Liu C . Self-assembled, aptamer-tethered DNA nanotrains for targeted transport of molecular drugs in cancer theranostics. Proc Natl Acad Sci U S A. 2013; 110(20):7998-8003. PMC: 3657780. DOI: 10.1073/pnas.1220817110. View

3.
Zhang T, Zhou M, Xiao D, Liu Z, Jiang Y, Feng M . Myelosuppression Alleviation and Hematopoietic Regeneration by Tetrahedral-Framework Nucleic-Acid Nanostructures Functionalized with Osteogenic Growth Peptide. Adv Sci (Weinh). 2022; 9(27):e2202058. PMC: 9507378. DOI: 10.1002/advs.202202058. View

4.
Horita M, Farquharson C, Stephen L . The role of miR-29 family in disease. J Cell Biochem. 2021; 122(7):696-715. PMC: 8603934. DOI: 10.1002/jcb.29896. View

5.
Chen Y, Tai H, Fu E, Don T . Guided bone regeneration activity of different calcium phosphate/chitosan hybrid membranes. Int J Biol Macromol. 2018; 126:159-169. DOI: 10.1016/j.ijbiomac.2018.12.199. View